Alzheimer's Disease Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with mild cognitive impairment or mild Alzheimer's disease, confirmed by a specific memory and thinking test (called the Montreal Cognitive Assessment) with a score between 17 and 25.
- People who have noticeable sleep problems, shown by a score above 5 on a standard sleep quality questionnaire (called the Pittsburgh Sleep Quality Index).
- People who live at home, in an independent living community, or in an assisted living facility.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are currently taking medication to help them sleep.
- People who live in a skilled nursing facility or long-term care facility.
- People who have significant vision problems such as cataracts that affect their sight, macular degeneration, or blindness.
- People who have been diagnosed with severe sleep apnea or restless leg syndrome.
- People who have a history of severe epilepsy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mariana Figueiro, PhD, Icahn School of Medicine at Mount Sinai
Phone: 518-242-4603
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cognition using the Montreal Cognitive Assessment (MoCA); Cognition using the Montreal Cognitive Assessment (MoCA); Cognition using the Montreal Cognitive Assessment (MoCA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.